Stevens-Johnson syndrome caused by cefepime?
Mavilia Luciano1, Trifiro’ Caterina2★, Mercuri Santo Raffaele1★ Corresponding author
- 1Dermatology and Cosmetology Unit, San Raffaele Hospital, Milano.
- 2Dermatology Unit, University Hospital “Gaetano Martino”, Messina, Italy.
CORRESPONDENCE
Trifiro’ Caterina
Dermatology Unit, University Hospital “Gaetano Martino”, Messina, Italy.
Received: 09-04-2014; Revised: 21-06-2014; Accepted: 28-06-2014.
Volume 6, Issue 1 · pp. 35–36 · PUBLISHED 2015 · DOI: 10.4103/0976-500X.149143
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
The clinical-dermatological picture and medical history allowed us to make an initial diagnosis of Stevens-Johnson syndrome (SJS), likely triggered by the administration of cefepime. SJS is a severe reaction to immunocomplex-mediated hypersensitivity, with a particular muco-cutaneous focus, which is attributable to the intake of medication in more than 80% of cases. Various categories of medication have been identified as triggers for SJS, like non-steroidal anti-inflammatory drugs (paracetamol, numesulide), anti-epileptic drugs (phenytoin, carbamazepine, valproic acid) and antibiotics (penicillin, tetracycline, cephalosporin). Until today no cases have been reported regarding the onset of SJS by cefepime, fourth-generation cephalosporin having a larger action spectrum, which is used in case of infection resistant to other forms of cephalosporin. Indicated for the treatment of infections in the lower respiratory tract, the genitor-urinary and pelvic tracts, skin and soft tissues, intra-abdomen and febrile states in immune-compressed patients, it is generally a well-tolerated drug with the most commonly reported adverse events being gastrointestinal (nausea, colitis, vomiting, diarrhea), neurological (cephalea) and cutaneous, or due to hypersensitivity like rash, itchiness and urticaria. Other than urticaria, among the skin conditions caused by cefepime described in scientific literature, red man syndrome, acute generalized exanthematous pustolosis and the case of SJS to which we make reference, induced by phenytoin and exacerbated by cefepime, can be found. Our case, therefore, seems to be first case in which SJS was triggered by cefepime, a hypothesis that was confirmed by the prompt resolution of the clinical status following the suspension of the drug and systemic methylprednisolone, 4 mg three times per day, and topical therapy with a fusidic acid 2% + hydrocortisone acetate 1% - based cream, three times per day. In consideration of the age of the patient and the issues related to elderly age, we cannot exclude the interference of other factors, such as the interaction between drugs or insufficient excretion playing an important role in the onset of skin reactions.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Luciano, M., Caterina, T., & Raffaele, M. S. (2015). Stevens-Johnson syndrome caused by cefepime?. Journal of Pharmacology and Pharmacotherapeutics, 6(1), 35–36. https://doi.org/10.4103/0976-500X.149143